Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. TMUS
10. LMT

Go back to Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock

Heron Therapeutics (HRTX) Announces Initiation of HTX-011 Phase 2

June 16, 2015 8:02 AM EDT

Heron Therapeutics (NASDAQ: HRTX) has initiated a Phase 2 clinical trial of HTX-011, the Companys lead product candidate for the prevention of post-operative pain, following clearance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for HTX-011. HTX-011, which utilizes Herons proprietary... More